Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drugs & Aging
Published in: Drugs & Aging 11/2015

01-11-2015 | Erratum

Erratum to: Antidiabetic Treatment Patterns in a Medicare Advantage Population in the United States

Authors: S. Lane Slabaugh, Yihua Xu, Jane N. Stacy, Jean C. Baltz, Yunus A. Meah, Jean Lian, D. Chad Moretz, Jonathan R. Bouchard

Published in: Drugs & Aging | Issue 11/2015

Login to get access

Excerpt

The numbers of patients listed in each cohort at the top of Table 3 are incorrect. …
Metadata
Title
Erratum to: Antidiabetic Treatment Patterns in a Medicare Advantage Population in the United States
Authors
S. Lane Slabaugh
Yihua Xu
Jane N. Stacy
Jean C. Baltz
Yunus A. Meah
Jean Lian
D. Chad Moretz
Jonathan R. Bouchard
Publication date
01-11-2015
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 11/2015
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-015-0317-2

Other articles of this Issue 11/2015

Drugs & Aging 11/2015 Go to the issue

Leading Article

Best Practices for Drug Prescribing in Older Adults: A Call for Action

Original Research Article

Quality of Life After Off-Label Thrombolysis for Ischemic Stroke in Elderly Patients

Original Research Article

Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between 2005 and 2009

Original Research Article

Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer’s Disease

Therapy in Practice

Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management

Original Research Article

Nurse Education to Reduce Harmful Medication Use in Assisted Living Facilities: Effects of a Randomized Controlled Trial on Falls and Cognition
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits